Trials / Terminated
TerminatedNCT02744833
Study to Assess Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-level Deep Venous Thrombosis (DVT)
A Randomized Phase I/II Study to Assess the Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-Level Deep Venous Thrombosis
- Status
- Terminated
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- GlycoMimetics Incorporated · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety profile of GMI-1271 and its effect on thrombus resolution in patients with distal calf vein Deep Venous Thrombosis (DVT).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GMI-1271 | |
| DRUG | Enoxaparin Sodium (Lovenox®) |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2016-11-01
- Completion
- 2016-11-01
- First posted
- 2016-04-20
- Last updated
- 2019-06-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02744833. Inclusion in this directory is not an endorsement.